Article info

Download PDFPDF

Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trial

Authors

  1. Correspondence to Dr Dinesh Khanna, Division of Rheumatology, University of Michigan, Ann Arbor, MI 48109, USA; khannad{at}med.umich.edu; Dr Oliver Distler, Department of Rheumatology, University Hospital Zurich, 8091 Zurich, Switzerland; oliver.distler{at}usz.ch
View Full Text

Citation

Khanna D, Allanore Y, Denton CP, et al
Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trial

Publication history

  • Received December 13, 2019
  • Revised February 19, 2020
  • Accepted March 9, 2020
  • First published April 15, 2020.
Online issue publication 
April 15, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.